160 related articles for article (PubMed ID: 25268905)
1. Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis.
Xiong J; Li Y; Huang K; Lu M; Shi H; Ma L; Luo A; Yang S; Lu Z; Zhang J; Yang L; Wang S
PLoS One; 2014; 9(9):e107272. PubMed ID: 25268905
[TBL] [Abstract][Full Text] [Related]
2. DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis.
Agodi A; Barchitta M; Quattrocchi A; Maugeri A; Vinciguerra M
PLoS One; 2015; 10(8):e0135078. PubMed ID: 26267895
[TBL] [Abstract][Full Text] [Related]
3. Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis.
Yuan W; Chen J; Shu Y; Liu S; Wu L; Ji J; Liu Z; Tang Q; Zhou Z; Cheng Y; Jiang B; Shu X
PLoS One; 2017; 12(9):e0184959. PubMed ID: 28934284
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of CDH13, DAPK1 and TWIST1 genes in precancerous and cancerous lesions of the uterine cervix.
Missaoui N; Hmissa S; Trabelsi A; Traoré C; Mokni M; Dante R; Frappart L
Pathol Res Pract; 2011 Jan; 207(1):37-42. PubMed ID: 21129853
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of Death-Associated Protein Kinase (DAPK1) and its association with oral carcinogenesis - An experimental and meta-analysis study.
Jayaprakash C; Varghese VK; Bellampalli R; Radhakrishnan R; Ray S; Kabekkodu SP; Satyamoorthy K
Arch Oral Biol; 2017 Aug; 80():117-129. PubMed ID: 28412611
[TBL] [Abstract][Full Text] [Related]
7. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
8. Identification of
Wang XB; Cui NH; Liu XN; Ma JF; Zhu QH; Guo SR; Zhao JW; Ming L
Front Genet; 2018; 9():258. PubMed ID: 30065752
[No Abstract] [Full Text] [Related]
9. Digital Loop-Mediated Isothermal Amplification-Based Absolute Methylation Quantification Revealed Hypermethylated DAPK1 in Cervical Cancer Patients.
Tan YL; Chen H; Wu ZK; He J; Jiang JH
Anal Chem; 2021 Jun; 93(22):8077-8083. PubMed ID: 34019386
[TBL] [Abstract][Full Text] [Related]
10. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis.
Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C
PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054
[TBL] [Abstract][Full Text] [Related]
11. Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
Cai F; Xiao X; Niu X; Zhong Y
PLoS One; 2017; 12(3):e0173194. PubMed ID: 28249042
[TBL] [Abstract][Full Text] [Related]
12. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA
Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402
[TBL] [Abstract][Full Text] [Related]
13. Association between Gene Promoter Methylation and Cervical Cancer Development: Global Distribution and A Meta-analysis.
El Aliani A; El-Abid H; El Mallali Y; Attaleb M; Ennaji MM; El Mzibri M
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):450-459. PubMed ID: 33441308
[TBL] [Abstract][Full Text] [Related]
14. Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.
Chang Z; Zhou H; Liu Y
Tumour Biol; 2014 Oct; 35(10):10503-13. PubMed ID: 25056535
[TBL] [Abstract][Full Text] [Related]
15. Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.
Huang J; Luo JY; Tan HZ
PLoS One; 2019; 14(10):e0222772. PubMed ID: 31574102
[TBL] [Abstract][Full Text] [Related]
16. Development of a multiplex MethyLight assay for the detection of DAPK1 and SOX1 methylation in epithelial ovarian cancer in a north Indian population.
Kaur M; Singh A; Singh K; Gupta S; Sachan M
Genes Genet Syst; 2016 Nov; 91(3):175-181. PubMed ID: 27452040
[TBL] [Abstract][Full Text] [Related]
17. Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
Fang C; Wei XM; Zeng XT; Wang FB; Weng H; Long X
BMC Cancer; 2015 Nov; 15():920. PubMed ID: 26585467
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis.
Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD
Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425
[TBL] [Abstract][Full Text] [Related]
20. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis.
Shi H; Li Y; Wang X; Lu C; Yang L; Gu C; Xiong J; Huang Y; Wang S; Lu M
PLoS One; 2013; 8(10):e76787. PubMed ID: 24116157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]